Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Pennsylvania ephedrine legislation

This article was originally published in The Tan Sheet

Executive Summary

Pennsylvania ephedrine legislation: HB 152, which passed the state House Feb. 11, is under consideration by the Senate Judiciary Committee. The bill, introduced by Rep. Ronald Marisco (R-105th district), would make the sale of or intent to sell ephedrine to minors a summary offense punishable by fine or imprisonment. Known as the "look-alike drug bill," the measure is directed at products that are "regularly marketed as stimulants or weight-loss aids and in their appearance look and in their effect act upon the body like illegal stimulants containing amphetamines." Exemptions are provided for ephedrine-containing products that "may lawfully be sold over-the-counter," are "labeled and marketed in a manner consistent with the pertinent" OTC monograph, and are "manufactured and distributed for legitimate medicinal use in a manner that reduces or eliminates the likelihood of abuse"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086728

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel